Your browser doesn't support javascript.
loading
Treatment of chronic GvHD with mesenchymal stromal cells induces durable responses: A phase II study.
Boberg, Erik; von Bahr, Lena; Afram, Gabriel; Lindström, Carina; Ljungman, Per; Heldring, Nina; Petzelbauer, Peter; Garming Legert, Karin; Kadri, Nadir; Le Blanc, Katarina.
Afiliación
  • Boberg E; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  • von Bahr L; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
  • Afram G; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Lindström C; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
  • Ljungman P; Department of Medicine, Karolinska Institutet Huddinge, Stockholm, Sweden.
  • Heldring N; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Petzelbauer P; Department of Medicine, Karolinska Institutet Huddinge, Stockholm, Sweden.
  • Garming Legert K; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Kadri N; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Le Blanc K; Skin and Endothelial Research Division, Department of Dermatology, Medical University of Vienna, Vienna, Austria.
Stem Cells Transl Med ; 9(10): 1190-1202, 2020 10.
Article en En | MEDLINE | ID: mdl-32573983

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Células Madre Mesenquimatosas Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Stem Cells Transl Med Año: 2020 Tipo del documento: Article País de afiliación: Suecia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Células Madre Mesenquimatosas Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Stem Cells Transl Med Año: 2020 Tipo del documento: Article País de afiliación: Suecia